| |
| |
|
| Insider
Information: |
Schlossberg Mark A |
| Relationship: |
SVP - Legal & General ... |
| City: |
Hayward |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
103,408 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,749,440 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
103,408 |
|
|
| Total
Value |
$6,749,440 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 12.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Impax Laboratories Inc |
IPXL |
SVP and General Counsel |
2018-05-04 |
0 |
2011-07-08 |
0 |
Premium* |
|
|
Cytokinetics Inc |
CYTK |
SVP - Legal & General ... |
2022-03-15 |
103,408 |
2020-03-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2022-03-15 |
4 |
S |
$33.96 |
$855,724 |
D/D |
(25,196) |
103,408 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2022-03-15 |
4 |
OE |
$7.03 |
$648,636 |
D/D |
60,817 |
128,604 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2022-03-07 |
4 |
D |
$36.83 |
$170,560 |
D/D |
(4,631) |
67,787 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
72,418 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2022-03-02 |
4 |
D |
$37.63 |
$130,087 |
D/D |
(3,457) |
52,418 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2022-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,025 |
55,875 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2021-10-19 |
4 |
AS |
$35.74 |
$713,970 |
D/D |
(19,979) |
50,850 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2021-10-19 |
4 |
OE |
$7.03 |
$140,452 |
D/D |
19,979 |
70,829 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2021-03-08 |
4 |
D |
$19.19 |
$79,639 |
D/D |
(4,150) |
50,850 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2021-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
55,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2020-08-21 |
4 |
AS |
$25.00 |
$250,000 |
D/D |
(10,000) |
30,000 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2020-08-21 |
4 |
OE |
$7.03 |
$70,300 |
D/D |
10,000 |
40,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2020-07-29 |
4 |
AS |
$23.07 |
$230,728 |
D/D |
(10,000) |
30,000 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2020-07-29 |
4 |
OE |
$7.03 |
$70,300 |
D/D |
10,000 |
40,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
• – – |
2020-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
• – – |
2018-05-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,135) |
0 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
• – – |
2018-05-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(50,116) |
0 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
• – – |
2018-03-02 |
4 |
D |
$19.50 |
$63,824 |
D/D |
(3,273) |
89,246 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
• – – |
2018-02-26 |
4 |
D |
$20.95 |
$124,380 |
D/D |
(5,937) |
92,519 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
• – – |
2017-05-15 |
4 |
D |
$16.80 |
$58,598 |
D/D |
(3,488) |
98,456 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
• – – |
2017-05-14 |
4 |
D |
$17.65 |
$57,098 |
D/D |
(3,235) |
101,944 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
• – – |
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
23,272 |
105,179 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
• – – |
2017-02-26 |
4 |
D |
$14.05 |
$84,497 |
D/D |
(6,014) |
81,907 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
• • – |
2016-05-23 |
4 |
D |
$32.12 |
$35,171 |
D/D |
(1,095) |
87,921 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
• • – |
2016-05-15 |
4 |
D |
$29.18 |
$67,989 |
D/D |
(2,330) |
89,016 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
